Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Development and validation of an individual sustainable diet index in the NutriNet-Santé study cohort.

Seconda L, Baudry J, Pointereau P, Lacour C, Langevin B, Hercberg S, Lairon D, Allès B, Kesse-Guyot E.

Br J Nutr. 2019 May;121(10):1166-1177. doi: 10.1017/S0007114519000369. Epub 2019 Apr 11.

PMID:
30973117
2.

Corrigendum: Environmental Impacts of Plant-Based Diets: How Does Organic Food Consumption Contribute to Environmental Sustainability?

Lacour C, Seconda L, Allès B, Hercberg S, Langevin B, Pointereau P, Lairon D, Baudry J, Kesse-Guyot E.

Front Nutr. 2018 Apr 18;5:26. doi: 10.3389/fnut.2018.00026. eCollection 2018.

3.

Environmental Impacts of Plant-Based Diets: How Does Organic Food Consumption Contribute to Environmental Sustainability?

Lacour C, Seconda L, Allès B, Hercberg S, Langevin B, Pointereau P, Lairon D, Baudry J, Kesse-Guyot E.

Front Nutr. 2018 Feb 9;5:8. doi: 10.3389/fnut.2018.00008. eCollection 2018. Erratum in: Front Nutr. 2018 Apr 18;5:26.

4.

Delta-toxin production deficiency in Staphylococcus aureus: a diagnostic marker of bone and joint infection chronicity linked with osteoblast invasion and biofilm formation.

Valour F, Rasigade JP, Trouillet-Assant S, Gagnaire J, Bouaziz A, Karsenty J, Lacour C, Bes M, Lustig S, Bénet T, Chidiac C, Etienne J, Vandenesch F, Ferry T, Laurent F; Lyon BJI Study Group.

Clin Microbiol Infect. 2015 Jun;21(6):568.e1-11. doi: 10.1016/j.cmi.2015.01.026. Epub 2015 Feb 10.

5.

The clinical status and survival in elderly dialysis: example of the oldest region of France.

Glaudet F, Hottelart C, Allard J, Allot V, Bocquentin F, Boudet R, Champtiaux B, Charmes JP, Ciobotaru M, Dickson Z, Essig M, Honoré P, Lacour C, Lagarde C, Manescu M, Peyronnet P, Poux JM, Rerolle JP, Rincé M, Couchoud C, Aldigier JC; REIN Limousin.

BMC Nephrol. 2013 Jun 25;14:131. doi: 10.1186/1471-2369-14-131.

6.

Bordetella holmesii bacteremia in a renal transplant recipient: emergence of a new pathogen.

Chambaraud T, Dickson Z, Ensergueix G, Barraud O, Essig M, Lacour C, Allard J, Bocquentin F, Aldigier JC, Rerolle JP.

Transpl Infect Dis. 2012 Dec;14(6):E134-6. doi: 10.1111/tid.12009. Epub 2012 Sep 24.

PMID:
22998023
7.

Efficiency of a turbidity-based, real-time control strategy applied to a retention tank: a simulation study.

Lacour C, Joannis C, Schuetze M, Chebbo G.

Water Sci Technol. 2011;64(7):1533-9. doi: 10.2166/wst.2011.545.

PMID:
22179653
8.

Real-time control of sewer systems using turbidity measurements.

Lacour C, Schütze M.

Water Sci Technol. 2011;63(11):2628-32.

PMID:
22049758
9.

Severe sirolimus-induced acute hepatitis in a renal transplant recipient.

Jacques J, Dickson Z, Carrier P, Essig M, Guillaudeau A, Lacour C, Bocquentin F, Aldigier JC, Rerolle JP.

Transpl Int. 2010 Sep;23(9):967-70. doi: 10.1111/j.1432-2277.2010.01100.x. Epub 2010 May 20.

10.

A model predicting waterborne cadmium bioaccumulation in Gammarus pulex: the effects of dissolved organic ligands, calcium, and temperature.

Pellet B, Geffard O, Lacour C, Kermoal T, Gourlay-francé C, Tusseau-vuillemin MH.

Environ Toxicol Chem. 2009 Nov;28(11):2434-42. doi: 10.1897/09-042.1.

PMID:
19606912
11.

Potential of turbidity monitoring for real time control of pollutant discharge in sewers during rainfall events.

Lacour C, Joannis C, Gromaire MC, Chebbo G.

Water Sci Technol. 2009;59(8):1471-8. doi: 10.2166/wst.2009.169.

PMID:
19403959
12.

Assessment of annual pollutant loads in combined sewers from continuous turbidity measurements: sensitivity to calibration data.

Lacour C, Joannis C, Chebbo G.

Water Res. 2009 May;43(8):2179-90. doi: 10.1016/j.watres.2009.02.017. Epub 2009 Feb 25.

PMID:
19303128
13.

Effects of differential blockade of the renin-angiotensin system in postinfarcted rats.

Lacour C, Roccon A, Galindo G, Canals F, Hogie M, Segondy D, Briand D, Roque C, Herbert JM, Nisato D.

Fundam Clin Pharmacol. 2004 Jun;18(3):299-307.

PMID:
15147281
14.

Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist.

Serradeil-Le Gal C, Wagnon J, Simiand J, Griebel G, Lacour C, Guillon G, Barberis C, Brossard G, Soubrié P, Nisato D, Pascal M, Pruss R, Scatton B, Maffrand JP, Le Fur G.

J Pharmacol Exp Ther. 2002 Mar;300(3):1122-30.

PMID:
11861823
15.

Aquaretic and hormonal effects of a vasopressin V(2) receptor antagonist after acute and long-term treatment in rats.

Lacour C, Galindo G, Canals F, Segondy D, Cazaubon C, Serradeil-Le Gal C, Roccon A, Nisato D.

Eur J Pharmacol. 2000 Apr 7;394(1):131-8.

PMID:
10771045
16.

[Development and validation of a perceived stress questionnaire recommended as a follow-up indicator in occupational medicine].

Consoli SM, Taine P, Szabason F, Lacour C, Metra PC.

Encephale. 1997 May-Jun;23(3):184-93. French.

PMID:
9333549
17.

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.

Serradeil-Le Gal C, Lacour C, Valette G, Garcia G, Foulon L, Galindo G, Bankir L, Pouzet B, Guillon G, Barberis C, Chicot D, Jard S, Vilain P, Garcia C, Marty E, Raufaste D, Brossard G, Nisato D, Maffrand JP, Le Fur G.

J Clin Invest. 1996 Dec 15;98(12):2729-38.

18.

Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models.

Lacour C, Canals F, Galindo G, Cazaubon C, Segondy D, Nisato D.

Eur J Pharmacol. 1994 Nov 3;264(3):307-16.

PMID:
7698170
19.

Pharmacological study of SR 47436, a non-peptide angiotensin II AT1-receptor antagonist, in conscious monkeys.

Lacour C, Roccon A, Cazaubon C, Segondy D, Nisato D.

J Hypertens. 1993 Nov;11(11):1187-94.

PMID:
8301099
20.

[Psychological and behavior characteristics predicting blood pressure reactivity to mental stress].

Lacour C, Consoli SM.

Arch Mal Coeur Vaiss. 1993 Aug;86(8):1177-80. French.

PMID:
8129524
21.

Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.

Serradeil-Le Gal C, Wagnon J, Garcia C, Lacour C, Guiraudou P, Christophe B, Villanova G, Nisato D, Maffrand JP, Le Fur G, et al.

J Clin Invest. 1993 Jul;92(1):224-31.

22.

Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist.

Cazaubon C, Gougat J, Bousquet F, Guiraudou P, Gayraud R, Lacour C, Roccon A, Galindo G, Barthelemy G, Gautret B, et al.

J Pharmacol Exp Ther. 1993 May;265(2):826-34.

PMID:
8496828
23.

[Perilunar dislocations of the carpus. Value of surgical treatment].

Lacour C, de Peretti F, Barraud O, Giboin P, Péquignot JP, Argenson C.

Rev Chir Orthop Reparatrice Appar Mot. 1993;79(2):114-23. French.

PMID:
8121995
24.

A pharmacodynamic study of the renin inhibitor SR 43,845, administered intratracheally in conscious cynomolgus monkeys.

Lacour C, Roccon A, Cazaubon C, Richaud JP, Segondy D, Nisato D.

J Hypertens Suppl. 1991 Dec;9(6):S384-5. No abstract available.

PMID:
1819002
25.

[Hypotensive effect of a new calcium antagonist, SR 33557 in conscious rats].

Lacour C, Canals F, Galindo G, Chatelain P, Nisato D.

Arch Mal Coeur Vaiss. 1990 Jul;83(8):1281-4. French.

PMID:
2124468
26.

Effects of a renin inhibitor, SR 43845, and of captopril on blood pressure and plasma active renin in conscious sodium-replete macaca.

Lacour C, Cazaubon C, Roccon A, Segondy D, Wagnon J, Nisato D.

J Hypertens Suppl. 1989 Apr;7(2):S33-5.

PMID:
2666612
27.

[Vertebral hydatid cyst. Apropos of 2 cases].

Argenson C, Griffet J, Lacour C, Arcamone H, Lovet J, de Peretti F.

Rev Chir Orthop Reparatrice Appar Mot. 1989;75(4):267-70. French.

PMID:
2781070
28.

[Chordoma of the cervical spine].

Griffet J, Perraud L, Lacour C, Paquis P, Grellier P.

Rev Chir Orthop Reparatrice Appar Mot. 1988;74 Suppl 2:299-301. French. No abstract available.

PMID:
3231805
29.

[Increase in plasma levels of active and inactive renin after inhibition of renin activity by SR 42128 in conscious Macaca monkeys].

Gougat J, Canat S, Lacour C, Cazaubon C, Gagnol J, Nisato D.

Arch Mal Coeur Vaiss. 1987 Jun;80(6):875-8. French.

PMID:
3116988
30.

Hemodynamic response to SR 42128A in normal and sodium-depleted baboons.

Serre M, Galindo G, Marion A, Lacour C, Cazaubon C, Gagnol JP, Nisato D.

J Cardiovasc Pharmacol. 1987;10 Suppl 7:S99-101.

PMID:
2485074
31.

In vitro and in vivo inhibition of human and primate renin by a new potent renin inhibitor: SR 42128.

De Claviere M, Cazaubon C, Lacour C, Nisato D, Gagnol JP, Evin G, Corvol P.

J Cardiovasc Pharmacol. 1985;7 Suppl 4:S58-61.

PMID:
2412015
32.

Pharmacological study of a new anti-inflammatory steroid, difluprednate (CM 9155).

Navarro J, Girard J, Lacour C, Unkovic J, Lafille C.

Arzneimittelforschung. 1978;28(12):2302-11. No abstract available.

PMID:
582948
33.

[Chemical and pharmacodynamic study of the derivatives of 2,4-dimethoxybenzoic acid].

Welcomme N, Lesieur D, Lespagnol C, Navarro J, Lacour C.

Ann Pharm Fr. 1976 Nov-Dec;34(11-12):439-46. French. No abstract available.

PMID:
1088060
34.

[Experimental production of cerebral edema by triethyltin sulfate].

Cahen R, Boucard M, Lalaurie M, Lacour C.

C R Acad Hebd Seances Acad Sci D. 1970 Nov 16;271(20):1816-9. French. No abstract available.

PMID:
4993191

Supplemental Content

Loading ...
Support Center